Concepedia

Muqing Li

ML

Statistics

Publications

8

Citations

385

H-Index

8

Active since

2019

Affiliations

University of Massachusetts Boston(Current)

University of Toronto

Princess Margaret Cancer Centre

Beth Israel Deaconess Medical Center

University Health Network

Muqing Li is an author at University of Massachusetts Boston specializing in molecular biology, molecular oncology, and medicine.

ORCID

Publications per year

2019–2024

8

Publications

8

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

Shuai Gao, Sujun Chen, Dong Han et al. · Nature Genetics · 2020 · 124 citations · Full text

, , +14

LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer

Muqing Li, Mingyu Liu, Wanting Han et al. · Cancer Research · 2023 · 68 citations · Full text

, , +17

Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs

Dong Han, Maryam Labaf, Yawei Zhao et al. · Journal of Clinical Investigation · 2024 · 41 citations · Full text

, , +17

RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition

Wanting Han, Mingyu Liu, Dong Han et al. · Oncogene · 2022 · 39 citations · Full text

, , +11

Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer

Wanting Han, Mingyu Liu, Dong Han et al. · Molecular Therapy · 2022 · 38 citations · Full text

, , +17

1–5 of 8